Back to search

Article

Real-World Diagnostic Accuracy of Fully Autonomous, FDA-Approved Artificial Intelligence Systems for Diabetic Retinopathy Screening in the United States: A Systematic Review and Meta-Analysis

2026-08-04

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> : Fully autonomous, FDA-approved artificial intelligence (AI) systems for diabetic retinopathy (DR) screening—LumineticsCore (formerly IDx-DR) and EyeArt—demonstrated high sensitivity and specificity in pivotal regulatory trials. Performance in real-world United States clinical practice, outside controlled trial conditions, has not been comprehensively pooled....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a1abbc4d-99c6-58dd-8b05-8735b477cecf
DOI
10.21203/rs.3.rs-10570689/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-World Diagnostic Accuracy of Fully Autonomous, FDA-Approved Artificial Intelligence Systems for Diabetic Retinopathy Screening in the United States: A Systematic Review and Meta-AnalysisDOI 10.21203/rs.3.rs-10570689/v1
Select a neighboring publication to make it the new centre.